Destroy the myth that marketing is just a shiny bow you add right before an IPO. If you want to break the "Commercialization Chokehold" that keeps brilliant Ontario science stuck on the bench, you need to realize that marketing is the strategic muscle that turns "trust me" into "fund me".
In this chapter, we cover:
First Things First: Why defensible science always beats vulnerable science. Before you can market effectively, you must de-risk your venture by ironcladding your global patent plan (IP) and clearly mapping your regulatory path to serve as your "commercial armour".
“Invisible Until You’re Investable” is a Trap: A breakdown of why staying in "stealth mode" during R&D is a fatal flaw. We discuss why you need to be visible, connected, and un-ignorable long before you actually need to ask for capital.
The Five Silent Killers: An audit of the critical communication mistakes keeping founders broke. We identify the five traps: using a dry "Grant-Writing Tone," throwing "Jargon Grenades," having vague "About Us" pages, building pitch decks with "Let's Circle Back" energy, and believing the myth that you can "market once you scale".
What Marketing Can and Can’t Do: A candid reality check on marketing's true capabilities. Discover how marketing acts as a megaphone to attract capital, top talent, and goodwill, while recognizing that it can never commercialize a bad product or magic away regulatory hurdles.
Branding is Not Hype (It's Belief Engineering): An exploration of the real currency in life sciences funding: belief. Learn how to craft a narrative, build credibility, and use storytelling to bridge the gap from cold, complex data to a compelling investment vision.
Are You Truly Visible OR JUST LOUD?: How to stop mistaking a flurry of digital activity for actual momentum. We outline the "Scoreboard of Success," helping you track metrics that drive actual commercial impact—like inbound inquiries and networking quality—so you stop skating in circles